0001600132-18-000177.txt : 20181123
0001600132-18-000177.hdr.sgml : 20181123
20181123162348
ACCESSION NUMBER: 0001600132-18-000177
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181120
FILED AS OF DATE: 20181123
DATE AS OF CHANGE: 20181123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dekker Martin
CENTRAL INDEX KEY: 0001643049
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36845
FILM NUMBER: 181199728
MAIL ADDRESS:
STREET 1: 53 FRONTAGE ROAD, SUITE 301
STREET 2: PERRYVILLE III CORPORATE PARK
CITY: HAMPTON
STATE: NJ
ZIP: 08827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001600132
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473116175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-574-4770
MAIL ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: Bellerophon Therapeutics LLC
DATE OF NAME CHANGE: 20140213
4
1
wf-form4_154300821209542.xml
FORM 4
X0306
4
2018-11-20
0
0001600132
Bellerophon Therapeutics, Inc.
BLPH
0001643049
Dekker Martin
C/O BELLEROPHON THERAPEUTICS, INC.
184 LIBERTY CORNER ROAD, SUITE 302
WARREN
NJ
07059
0
1
0
0
VP of Engineering & Manuf
Stock Option (right to buy)
0.91
2018-11-20
4
A
0
137500
0
A
2028-11-20
Common Stock
137500.0
250483
D
This option was granted on November 20, 2018. This option vests in quarterly installments over a four-years period from the date of grant.
/s/ Martin Dekker
2018-11-20